Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's their problem....double-speak and vagueness: "actively engaged in seeking a journal publication." Tells me no one has accepted it. I am actively engaged in seeking the truth...
Not a short narrative as many keep saying. It's a communication problem the company created and is perpetuating. This can all be cleared up with one PR and they CHOOSE not to do it.
Yep. And my recent favorite, when asking WTF was going on with the 20 month quiet period resulting in TLD then Journal...."We said TLD and a journal publication were our goals."
We somehow need to break through and hold above .74 to get this moving back in the right direction. Many thought we would get catalysts from company communications...definition of insanity. Self-imposed quiet period is now a self-imposed embargo?, can't make this shit up. More like a self-imposed downward spiral. They are following conventional wisdom with regard to tip-toeing around FDA and Journals. Conventional wisdom is, by definition, backwards thinking. This is a new world and you need to win in public, social media, screaming from the rooftops. The current strategy could leave us buried at $0 with no one ever hearing about it. This needs to change.
I don't think there are enough (actionable) warrants left to really matter, If there are approx 1.1 Billion shares outstanding and LP,LG,MB, etc. have approx 200 million (?) combined that they cannot exercise, we are almost done.
No, sure it would. Last time 70M shares moved the stock from $2 to .38!
Shhhh!!! NWBO wants to keep this quiet. We even hired an outside PR firm to help keep it quiet.
18 patients in early stage rectal cancer. No indication it will be used for other types. Larger study will commence. However, the lab produced cells injected back into the patient is eerily similar.
Why isn't NWBO shouting from the rooftops!!!!! Ridiculous.
Mgmt is full of it. No transparency, 21 months of silence on the P3 telling us TLD and Journal. They sit on TLD for how long trying to get a Journal to publish? No one knows. Now, no Journal....it was just a goal.
The fact that after positive TLD release, and all the supposed interest from institutional investors (and large individual investors), we can't get a couple hundred million shares bought to drive out the shorts and nefarious entities? A hundred million dollars? These days? Chump change for a potential 50X return and being part of the next SOC. I just don't get it.
Ask DI yourself. He will tell you the same thing he has told multiple people here...TLD was presented at NYAS.
Unfortunately, all we can sell is to UK specials for those who can afford it without reimbursement. Formal TLD/Journal and a competent PR firm and willing CEO to let them tell the story....that's what we need or we have nothing to sell and limited resources to get there. They need to stop with the nonsense (quiet periods and embargos) and be honest with shareholders. What's the F'in plan and timelines?
Cart before the horse. We do not have a product to sell! Where is formal TLD and Journal? If we had that first, then talk of manufacturing, maybe.
Soooooo, based on the facts, from the company's own words, they are not confusing anyone? It's "people on the internet"?
The company caused this confusion and subsequent semantic argument. You are either pregnant or not pregnant. They did not PR TLD on May 10th....Fact. They did include a new line in the "about NWBO" section of June 5th PR stating "This Phase III trial reached data lock and top line data was recently presented."....also Fact.
So, which is it? The fact that anyone has to ask means the company is inept.
At the same time a poster this morning said DI confirmed that TLD had been released? I have never seen this in 40 years of investing with any other company, large or small. I support the science. However, anyone who believes this has been handled correctly for the last several years, especially the last 20+ months, is not being honest...or maybe a paid pumper.
After billions of dollars and 17 years, this is the TLD announcement? Scroll all the way down....
"Northwest Biotherapeutics Announces Presentations On DCVax®-L Personalized Vaccines, Manufacturing and Scale-Up, and DCVax®-L Clinical Program
BETHESDA, Md., June 5, 2022 – Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported that yesterday on June 4, 2022, in the Industry Expert Theater during the ASCO 2022 conference, Dr. Marnix Bosch made a presentation discussing the Company’s DCVax-L technology for personalized dendritic cell vaccines, the Sawston, UK facility, the manufacturing technology, the development of automation, and preparations for manufacturing scale-up. In addition, a video presentation about the DCVax®-L clinical program was screened in the Company’s exhibit booth in the ASCO Exhibit Hall.
These presentations are now available online at https://virtualtrials.org/dcvax
The Industry Expert Theater is not an official event of the ASCO Annual Meeting. It is not sponsored, endorsed or accredited by ASCO®, CancerLinq®, or Conquer Cancer® the ASCO Foundation. It is not CME-accredited.
About Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both North America and Europe. The Company has a broad platform technology for DCVax® dendritic cell-based vaccines. The Company’s lead program is a 331-patient Phase III trial of DCVax®-L for newly diagnosed and recurrent Glioblastoma multiforme (GBM). GBM is the most aggressive and lethal form of brain cancer, and is an “orphan disease.” This Phase III trial reached data lock and top line data was recently presented. The Company has also developed DCVax®-Direct for inoperable solid tumor cancers. It has completed a 40-patient Phase I trial and, as resources permit, plans to pursue Phase II trials. The Company previously conducted a Phase I/II trial with DCVax-L for advanced ovarian cancer together with the University of Pennsylvania.
The fact that there is confusion and debate over whether TLD was released or not says everything about the failed strategy of NWBO mgmt. On May 10th they DID NOT say it was a TLD release. On 6/5 they added a line below the actual PR substance to say that it was released. If you think that is the best way to do it and covers it after 17 years, more power to you. Foolish and idiotic from a company with 6 advisory boards and a contracted PR firm.
So states NWBO itself, a month after it happened. Again, Idiotic, IMO.
Their PR did not say that. They have not publicly said that anywhere. TLD release is not something a Journal can stop you from doing while embargoed. And yet, that's it? Nothing from the company. Idiotic. They have been saying for 2 years that they would release TLD and Journal. No PR on TLD and still no Journal. They said they were waiting until Journal acceptance so they could have TLD and Journal as close together as possible. It has been a month since the supposed TLD release. Again, can't make this stuff up....
Right, but the confusion as to whether or not TLD has been presented? Unheard of....
Has anyone spoken to the company and asked them?
Stock going lower, no clarity, no timelines, no Journal....can't make this up.
A late PR, very little new info. TLD? No TLD? Is it out, not out, embargoed? I just don't get it. Another opportunity lost, IMO, by NWBO mgmt. WTF is going on?
Why wouldn't it? LP and crew standing there with hands in pockets, blindfolds on, duct tape over their mouths...all while the in the octagon with punches flying in from everywhere.
hate-filled? Please. More like an honest recap of the ineptitude of mgmt.
Yup, we will end up red the day of the start to a game-changing conference presentation.....zero trust by the market in this.
Seriously doubt it after the May 10th smashdown.
NWBO, it's mgmt and IR have lost all credibility with me. They have shown they are incapable of handling any situation properly...much less with any transparency. They couldn't make the right turn with the map upside down. It appears you will be able to buy ad sell this stock at higher and then lower prices for a while to come. Until they change their strategy and inform investors where we are and what the plan is, there is no one willing to start buying this stock in volume. F@#k the said embargo, same with this ridiculous quiet period. Whoever has been advising this team (and LP, has been listening) has no idea what they are doing. These people will use any excuse in the book to be afraid of their own shadows. It's too bad that the only people suffering more than shareholders are the patients!
Unless we hear something by their usual 1030am PR release, there will be nothing new at ASCO. And, if that is the case, after the debacle in handling NYAS, we will go lower in PPS, guaranteed.
Typical nonsense, double-speak. Sounds to me like they are still chasing a Journal, not waiting for publication date. Awful.
I am also concerned about the PPS. I get it, we had the AF attack and FUDsters and likely a massive coordinated short attack. But now, it's eerily silent? Still nothing from the company. Still silent on TLD/Journal. Still unsure if anything new will happen at ASCO. They knocked this down to .38 from $2 last time! It's almost as if I feel they are waiting in the wings for ASCO to do it again....then where does the price go?
I know there are some who will say it doesn't matter. But it does. If there were any guidance given by the company (that actually happen on time) to instill confidence, great. But we don't even have an ASM scheduled, so even that is late.
And, hopefully the pushback/smackdown AF got after NYAS will prevent the same nonsense after ASCO, and let the real truth out!
Ok. He did post something regarding MRK at ASCO and it's pipeline of drugs.
Did you mean Pete Najarian? If so, can you repost his tweet? I can not find it. Thanks.
Heading into ASCO week at .68. Unless the company can publicly speak about the results and counter the negativity, I do not see any run up into the meeting. Not sure they can even say much there. If we don't get something today or tomorrow it's going to be a tough week, IMO.
Different circumstances then, though. If we are currently limited in speaking of trial data due to embargo, very little new info can/will be revealed. Maybe expand on and clarify what was presented at NYAS, since that is public.
Yes, but LL is the principal investigator on the trial. She may be included in any embargo. Same with Bosch. Ashkan may not be. Either way it likely means they are preparing for no news by ASCO, IMO.
They may have convinced Ashkan to come and speak similar to the LL switch to Mulholland at NYAS. Bosch, as an employee and trial director, may be limited if no PR or Journal prior to ASCO. Maybe they will both be there just in case? However, I am not holding my breath. We will be passing 20 months since data lock during ASCO.
After the chaos form NYAS I think we will see light trading until mid week and then a potential run up into ASCO. If no PR or Journal on Wed/Thursday, I am not sure what will happen.
If he is really going to be there, where else could he speak? Nothing on scheduled agenda.